Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients.

ABSTRACT:

Background

Identifying lung cancer patients at an increased risk of getting SARS-CoV-2-related complications will facilitate tailored therapy to maximize the benefit of anti-cancer therapy, while decreasing the likelihood of COVID-19 complications. This analysis aimed to identify the characteristics of lung cancer patients that predict for increased risk of death or serious SARS-CoV-2 infection.

Patients and methods

This was a retrospective cohort study of patients with lung cancer diagnosed October 1, 2015, and December 1, 2020, and a diagnosis of COVID-19 between February 2, 2020, and December 1, 2020, within the Veterans Health Administration. Serious SARS-CoV-2 infection was defined as hospitalization, ICU admission, or mechanical ventilation or intubation within 2 weeks

SUBMITTER: Ganti AK 

PROVIDER: S-EPMC9977088 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature